Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Margolis S, Carter HB: Prostate disorders. In The Johns Hopkins White Paper. Baltimore: Johns Hopkins Medicine; 2002.
2. Lepor H: Challenges in the detection and diagnosis of bladder dysfunction: optimal strategies for the primary care physician. Rev Urol 2004, 6(Suppl 1):S1–S2.
3. McConnell JD, Roehrborn CG, Bautista OM, et al.: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003, 349:2387–2398.
4. Barkin J, Guimarães M, Jacobi G, et al.: Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5-alpha-reductase inhibitor dutasteride. Eur Urol 2003, 44:461–466.
5. Fitzpatrick JM: Should combination therapy be standard for benign prostatic hyperplasia? Nat Clin Pract Urol 2005, 2:574–575.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献